Combating the Drug Epidemic
Neonatal Abstinence Syndrome
Neonatal abstinence syndrome is the name given to newborns suffering from drug withdrawal resulting from the mother’s use of drugs during pregnancy. No baby should be born suffering from withdrawal from heroin, methamphetamine, oxycodone and other highly addictive drugs.
Congressman Evan Jenkins is fighting every day to help these newborns and to ensure that they receive the best possible care.
After multiple meetings with doctors, nurses, caregivers, and families, he drafted the Nurturing and Supporting Health Babies Act. This bill will expand what we know about NAS and will make significant strides in guaranteeing the best possible care for babies with NAS. This bill was passed by the House and included in the Comprehensive Addiction and Recovery Act, which was signed into law. Congressman Jenkins has also introduced the Cradle Act which requires guidelines to be put in place to make it easier to open residential pediatric recovery centers, which specialize in the treatment of NAS babies.
Treatment and Recovery
Congressman Evan Jenkins has advocated for increased funding for the Substance Abuse and Mental Health Administration to ensure that states have the resources necessary to implement much-needed mental health services. He has also championed increased funding for drug courts and veterans treatment courts – programs that work. These courts offer treatment and assistance in getting one’s life back on track.
Congressman Evan Jenkins was a proud supporter of the Comprehensive Addiction and Recovery Act, which was signed into law. This bill will make significant strides to help our communities fight the opioid and heroin epidemic by creating new grant programs that focus on community efforts, getting money to those who know best how to use it. It also has a number of other measures that focus on treatment, recovery and prevention.
Thanks to his work on the House Appropriations Committee, Congressman Jenkins was able to secure language that would help keep the focus on Appalachia and West Virginia when securing grant funding for drug abuse programs. Recently Congressman Jenkins voted to increase SAMHSA’s Drug Abuse Prevention by $500 million. In addition to this, Congressman Jenkins has advocated for millions of dollars more in funding to fight the drug crisis and make sure treatment and prevention remain a critical part of our efforts.
Representative Jenkins fought through the appropriations process to increase funding for the High Intensity Drug Trafficking Areas (HIDTA), a program that brings together local, state, and federal law enforcement in order to stop the flow of drugs into our communities. HIDTA also works closely with the community to stop drug abuse problems before they begin. Recently, Rep. Jenkins introduced an amendment to increase HIDTA by $2 million, which was adopted on the House floor unanimously. Funding for this program makes a significant difference in law enforcement’s efforts to stop drug trafficking.
Evan also advocated as a member of the House Appropriations Committee to secure funding for the Byrne JAG police grants program. This program allows local law enforcement to use federal grant money in the ways that will best help the community. He will continue to be an advocate for our law enforcement and their efforts to combat the drug epidemic in West Virginia. He also continues to fight for programs that will keep heroin off our streets, like fully funding the heroin task forces and the National Guard counterdrug programs.
More on Combating the Drug Epidemic
WASHINGTON – U.S. Representative Evan Jenkins (R-W.Va.) announced today that West Virginia has received federal approval to cover treatment for neonatal abstinence syndrome, exposure to drugs like opioids during pregnancy. West Virginia is now the first state federally approved to cover NAS treatment at centers like Lily’s Place.
WASHINGTON – U.S. Representative Evan Jenkins (R-W.Va.) issued the following statement after voting yes to pass the Bipartisan Budget Act, which funds the government through March 23:
“President Trump has asked for the Bipartisan Budget Act to provide critical funding for our national security. This legislation establishes a budget framework that will allow us to fund our nation’s military, strengthen our border security, provide two years of funding for community health centers, renew CHIP for 10 years, and invest in infrastructure.
WASHINGTON – U.S. Representative Evan Jenkins (R-W.Va.) issued the following statement after employees of Lily’s Place were verbally harassed because of support from the Trump administration:
WASHINGTON – U.S. Representative Evan Jenkins (R-W.Va.) issued the following statement today on the nomination of Alex Azar as the new secretary of Health and Human Services:
WASHINGTON – U.S. Representative Evan Jenkins (R-W.Va.) issued the following statement regarding the news that Cardinal Health CEO George Barrett is stepping down:
WASHINGTON – The President’s Commission on Combating Drug Addiction and the Opioid Crisis today urged the Trump administration to support passage of the Prescription Drug Monitoring Act, legislation introduced by U.S. Representative Evan Jenkins (R-W.Va.). This bill would push states to enhance their use of prescription drug monitoring programs, a powerful tool to prevent opioid abuse.
WASHINGTON – U.S. Representatives Evan Jenkins (R-W.Va.) and Annie Kuster (D-N.H.) introduced legislation today to ensure federal opioid epidemic funding goes to the states most affected, like West Virginia and New Hampshire.
Their legislation, the Federal Opioid Response Fairness Act, would ensure that states most affected by the opioid crisis receive much-needed resources under the 21st Century Cures Act, which authorized $1 billion in funding to address the drug crisis.
WASHINGTON – U.S. Representative Evan Jenkins (R-W.Va.) praised the Drug Enforcement Administration’s announcement today that it is establishing a new heroin and fentanyl enforcement team in Charleston.
This team will improve the DEA’s response to stop trafficking in heroin, fentanyl and similar drugs in communities disproportionately impacted by the opioid crisis.
WASHINGTON – U.S. Representative Evan Jenkins (R-W.Va.) attended President Trump’s opioid announcement Thursday at the White House and issued the following statement after the event:
WASHINGTON – U.S. Representative Evan Jenkins (R-W.Va.) has been invited by President Trump to attend the president’s opioid announcement Thursday at the White House.